Printer Friendly
The Free Library
14,380,430 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Vaccines industry topic

Subtopics (35)

 

Articles

1-100 out of 100 article(s)
Title Author Type Date Words
Claimants Forced to File Thimerosal Suits First in Vaccine Court. Jul 6, 2004 1969
InNexus Biotechnology, Inc.: Update on SuperAntibody Partnering Program. Jun 23, 2004 452
Kirin and Geron Announce Settlement of Lawsuit. Jun 22, 2004 290
Merix and Kirin To Develop Personalized Dendritic Cell Vaccines For Cancer, HIV and Other Diseases. Jun 22, 2004 586
DOR BioPharma and Thomas Jefferson University Collaborate With U.S. Army to Advance Development of Botulinum Toxin Vaccines. Jun 16, 2004 1242
Corixa to Participate at Needham & Company Biotechnology Conference. Jun 15, 2004 290
Corixa Appoints Christof Marre to Lead Global Commercial Marketing Efforts. Jun 14, 2004 634
Enzo Biochem Granted European Patent for Displacer Technology to Treat Gene Abnormalities; Methodology Could Make Possible Modification or Corrections of Cell Mutations. Jun 14, 2004 662
Enzo Biochem To Present At Needham & Company Third Annual Biotechnology Conference. Jun 10, 2004 356
Merix Bioscience Launches Trial for New Kidney Cancer Vaccine. Jun 8, 2004 737
Enzo Biochem, Inc. Files Patent Infringement Lawsuit Involving DNA Sequencing against Applera Corp. and Subsidiary. Jun 8, 2004 500
CancerVax Announces Retrospective Analyses of Phase 2 Data on Its Investigational Agent Canvaxin in the Treatment of Patients with Stage IV Melanoma. Jun 7, 2004 1106
Novel Cancer Compound Targeting EGFR Pathway Demonstrates Positive Phase 1/2 Clinical Trial Results. Jun 7, 2004 1375
CancerVax Corporation to Host Webcast on Saturday, June 5 at 12:45 p.m. Central Time. Jun 3, 2004 405
Corixa to Participate at Pacific Growth Equities Conference. Jun 3, 2004 284
CancerVax to Webcast Corporate Presentation at Pacific Growth Equities Life Sciences Growth Conference. Jun 3, 2004 342
Enzo Rejects Roche Settlement Offer; Roche Responds With Lawsuit. Jun 3, 2004 492
Gregory Sessler. Brief Article Jun 1, 2004 30
Enzo Biochem to Begin Clinical Trial on New Immunomodulatory Agent. May 20, 2004 659
Corixa and the Australian Nuclear Science and Technology Organization Sign License and Supply Agreements for BEXXAR Rights in Australasia. May 19, 2004 750
Enzo Biochem Presenting Preclinical Data on Compound for Treating Immune Mediated Disorders. May 17, 2004 686
Elan to Sponsor the 9th International Conference on Alzheimer's Disease. May 17, 2004 618
DOR BioPharma, Inc. Announces First Quarter 2004 Financial Results. May 17, 2004 969
Corixa to Participate at Banc of America Securities Healthcare Conference. May 17, 2004 282
CancerVax Corporation Reports First Quarter 2004 Financial Results. May 13, 2004 2066
Sonus Pharmaceuticals Appoints Michelle Burris to Board of Directors. May 6, 2004 761
CancerVax Corporation to Host Conference Call and Live Webcast to Discuss First Quarter 2004 Financial Results. May 6, 2004 592
Corixa Announces First Quarter Financial Results. May 5, 2004 1698
ENZO BIOCHEM REPORTS INTERIM RESULTS FOR ALEQUEL TRIAL. May 1, 2004 727
Stock Market Ratings by StockPickReport.com for Apple Computer Inc., Eagle Broadband Inc., Annaly Mortgage Management Inc., Medarex Inc and International Rectifier Corp. May 1, 2004 313
Geron Corporation Reports 2004 First Quarter Financial Results and Events. Apr 29, 2004 1120
Preclinical Data Confirm Anti-Angiogenic Effects of CancerVax Monoclonal Antibody. Apr 29, 2004 884
Seattle Genetics Reports First Quarter 2004 Results. Apr 27, 2004 1479
Conference Call/Webcast Alert: Corixa Corporation First Quarter 2004 Earnings Conference Call. Apr 27, 2004 173
Corixa Announces Initiation of Phase I Clinical Trial of CRX-675 in Patients with Seasonal Allergic Rhinitis. Apr 26, 2004 1726
Stock Market Ratings by StockPickReport.com for Nextel Communications, Biogen Idec, CarMax, Protein Design Labs and Monsanto Company. Apr 26, 2004 311
Sinovac Biotech Ltd. to Test Fully Human Antibody Developed by Massachussets Biotech Laboratories and Medarex for its Ability to Neutralize the SARS Virus. Apr 26, 2004 1213
Corixa to Present at SunTrust Robinson Humphrey ''Off the Cuff'' Therapeutics Conference. Apr 26, 2004 273
ADVISORY/Experts Available to Discuss Melanoma Awareness. Apr 26, 2004 604
BioThrax Vaccine Monograph Listed in USP. Apr 23, 2004 288
AVANT Receives Additional Defense Contract for Clinical Testing of Plague Component for Oral Anthrax/Plague Vaccine. Apr 21, 2004 1012
AVANT Immunotherapeutics Reports First Quarter Fiscal 2004 Financial Results. Apr 21, 2004 1622
Stock Market Ratings by StockPickReport.com for Nextel Communications, Biogen Idec, CarMax, Protein Design Labs and Monsanto Company. Apr 19, 2004 311
DOR BioPharma Announces Annual Meeting Date. Apr 14, 2004 196
Stock Market Ratings by StockPickReport.com for Nextel Communications, Biogen Idec, CarMax, Protein Design Labs and Monsanto Company. Apr 12, 2004 312
Stock Market Ratings by StockPickReport.com for Apple Computer Inc, Eagle Broadband, Annaly Mortgage Management Inc, Medarex Inc, International Rectifier Corp. Apr 10, 2004 312
Local biotechs pitch findings at cancer conference: data presented looks toward the future. Webb, Marion Apr 5, 2004 574
Zacks.com Announces That Paul Tracy Highlights the Following Stocks: Nektar Therapeutics, Corixa Corporation, and OSI Pharmaceuticals. Apr 1, 2004 846
Web site--directed to farmers, ranchers & growers. Brief Article Apr 1, 2004 105
Companion animal public relations campaign. Brief Article Apr 1, 2004 78
Corixa Announces Appointment of Gregory Sessler to Its Board of Directors and Departures of Joseph Lacob and Michael Bigham. Mar 31, 2004 833
CancerVax Presents Preclinical Data on Anti-Tumor Effects of Angiogenesis Inhibitors; Data Presented at AACR Annual Meeting. Mar 31, 2004 1000
CancerVax Announces Presentation of Phase 2 Data on Canvaxin in the Treatment of Stage II Melanoma; Data Presented at AACR Annual Meeting. Mar 31, 2004 1100
DOR BioPharma Reports Fourth Quarter and Year End Financial Results and Accomplishments for 2003. Mar 31, 2004 1243
Corixa Announces Adjuvant License and Supply Agreements with Aventis; Rights to Corixa's RC-529 Adjuvant Licensed for Multiple Aventis Vaccines. Mar 30, 2004 770
Commonwealth Biotechnologies, Inc. Launches New Biodefense Business Initiative; Signs Broad Teaming Agreement with DynPort Vaccine. Mar 30, 2004 606
Aphios Corporation Awarded Innovative Research Grant from National Institute of Allergy & Infectious Diseases, NIH to Develop Novel Anti-HIV Therapeutics. Mar 23, 2004 423
Enzo Biochem Reports on Preclinical Study That Points to Development of New Compound for Treating Immune Mediated Diseases. Mar 23, 2004 679
Stock Market Ratings by StockPickReport.com for Rambus, QUALCOMM, Alcoa, Dynegy and Protein Design Labs. Mar 21, 2004 377
Corixa to Participate in Multiple Presentations at Invest Northwest 2004. Mar 16, 2004 312
Aphios Corporation Executes Material Transfer Agreement with National Cancer Institute, NIH For Natural Products to Discover and Develop Novel Anticancer and Antiviral Therapeutics. Mar 16, 2004 370
DOR BioPharma Closes $3.25 Million Private Placement. Mar 15, 2004 533
CancerVax Licenses Novel Technology That Appears to Arrest Uncontrolled Cancer Cell Growth. Mar 15, 2004 1160
Enzo Biochem Reports Interim Results for Clinical Trial of Alequel, Its Investigational Treatment for Management of Crohn's disease. Mar 11, 2004 855
Stock Market Ratings by StockPickReport.com for General Electric, NVIDIA, eBay, Dynegy and Protein Design Labs. Mar 8, 2004 375
CancerVax wins recommendation. Webb, Marion Brief Article Mar 8, 2004 110
DOR Announces Conversion of All Outstanding Preferred Stock into Common Stock. Mar 4, 2004 578
DOR BioPharma, Inc. Announces Private Equity Financing of $3.25 Million. Mar 4, 2004 735
BioPort Supplies FDA-Licensed Anthrax Vaccine to Taiwan. Mar 4, 2004 316
Corixa to Present at SG Cowen Health Care Conference. Mar 3, 2004 287
CancerVax to Webcast Corporate Presentation at SG Cowen Annual Healthcare Conference. Mar 3, 2004 556
Stock Market Ratings by StockPickReport.com for General Electric, NVIDIA, eBay, Dynegy and Protein Design Labs. Mar 3, 2004 375
CancerVax Corporation Announces Fourth Quarter and Full Year 2003 Financial Results. Mar 2, 2004 2342
Abbott Laboratories and Corixa Enter into Agreement for Chagas' Disease Blood Screening Technology. Mar 2, 2004 1145
Corixa and GSK Settle BEXXAR Patent Litigation with Biogen Idec. Mar 1, 2004 685
Data and Safety Monitoring Board Recommends That CancerVax Continue Canvaxin Phase 3 Clinical Trial for Stage III Melanoma. Mar 1, 2004 896
Aventis and Intercell form bacterial vaccine collaboration. Mar 1, 2004 382
CancerVax to Webcast Corporate Presentation at Lehman Brothers Annual Global Healthcare Conference. Feb 27, 2004 568
Enzo Biochem Acquires Assets of OraGen Corporation, a Biotech Firm Involved in Immune Regulation. Feb 26, 2004 718
Stock Market Ratings by StockPickReport.com for Diomed, OmniVision, US Bancorp, Dynegy, Protein Design Labs. Feb 26, 2004 378
CancerVax Corporation to Host Conference Call and Live Webcast to Discuss Fourth Quarter and Year End 2003 Financial Results. Feb 24, 2004 567
Corixa to Present at Lehman Brothers 7th Annual Global Healthcare Conference. Feb 24, 2004 281
Stock Market Ratings by StockPickReport.com for Akamai Technologies, DOR BioPharma, Mattel, Lilly Eli & Co and ActivCard. Feb 20, 2004 354
CancerVax to Webcast Corporate Presentation at BIO CEO & Investor Conference. Feb 18, 2004 703
Conference Call/Webcast Alert: Corixa Corporation Fourth Quarter 2003 and Year-End Earnings Conference Call. Feb 18, 2004 176
Stock Market Ratings by StockPickReport.com for Akamai Technologies Inc., DOR BioPharma Inc., DF China Technology Inc., Schlumberger Ltd., Goldman Sachs Group Inc. Feb 15, 2004 380
DOR BioPharma, Inc. Announces Appointment of Dr. James S. Kuo and Stuart D. Sedlack to Its Board of Directors. Feb 12, 2004 882
CancerVax to Webcast Corporate Presentation at Roth Capital Partners Conference. Feb 10, 2004 550
Stock Market Ratings by StockPickReport.com for Yahoo!, DOR BioPharma, Ableauctions.com, Clear Channel Communications, Centillium Communications. Feb 6, 2004 379
DOR BioPharma, Inc. Provides Update on Ricin Vaccine Development Program. Feb 4, 2004 783
Protein Design Labs receives license fees for humanized antibodies. Feb 1, 2004 388
In November, Affymetrix filed a complaint against Enzo BioChem for declaratory judgment. Brief Article Jan 31, 2004 30
AVANIR and VaxGen Form Alliance to Develop and Manufacture Anthrax Antibody. Jan 29, 2004 1405
VaxGen, Inc. to Present at the 11th Annual Emerald Groundhog Day Investment Forum. Jan 29, 2004 293
CancerVax to Webcast Corporate Presentation at Piper Jaffray Health Care Conference. Jan 22, 2004 573
Corixa and GSK Biologicals Announce Plans to Initiate a Human Clinical Study in the U.S. for a Novel Tuberculosis Vaccine. Jan 14, 2004 1056
Phase I/II HIV Gene Therapy Trial Initiated Enzo Biochem Tells Annual Meeting. Jan 14, 2004 757
Seattle Genetics Announces Expansion of ADC Collaboration with Protein Design Labs. Jan 12, 2004 659
SARS vaccine triggers immunity in monkeys. Brief Article Jan 10, 2004 212
Genentech and Protein Design Labs settle antibody patent dispute. Dec 1, 2003 461

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles